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Section 1 
A 30 year old female patient presented with a history of generalized tonic-clonic seizures 
since childhood, occurring for the first time at the age of nine. The initial diagnostic work-up 
at age 13 demonstrated a distinctive calcified mass of the left frontal lobe on computerized 
tomography (CT) (Fig. 1A). Together with a single facial nevus, the lesion was suspected to 
represent Sturge-Weber-like phakomatosis, however, the patient’s clinical history and 
physical examination failed to reveal further evidence of a neurocutaneous syndrome. 
Neither magnetic resonance imaging (MRI) nor biopsy for histological confirmation of the 
diagnosis was performed. At age 18, the patient was lost to follow-up at the Children’s 
hospital. 
At age 30, the patient, who had been on permanent antiepileptic treatment with valproic acid, 
suffered a generalized seizure prompting clinical and radiological re-assessment. The 
reported facial nevus was no longer detectable and the patient was free of neurological 
symptoms or signs. CT scan of the head revealed calcified masses of the left and right 
frontal lobes (Fig. 1B), with considerable progression when compared to the initial CT scans 
obtained 17 years before.  
 
- What is the differential diagnosis? 
- What are suitable diagnostic measures? 
 
Section 2 
In the absence of significant clinical findings, the radiological differential diagnosis based on 
CT scans is broad including various primary and secondary brain tumors. Neoplasms with 
dense calcifications include, among others, oligodendroglioma, ganglioglioma and 
meningioma. Vascular pathologies including cavernous malformations or aneurysms and 
infectious lesions with calcifications such as tuberculosis must be considered. Furthermore, 
Sturge-Weber syndrome and other neurocutaneous disorders can be associated with cortical 
calcifications. More advanced imaging techniques may be helpful to allow for a more precise 
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diagnosis. An MRI scan confirmed the bifrontal masses with distinctive signal alterations on 
T1- and T2/FLAIR-weighted sequences of the surrounding brain parenchyma interpreted as 
chronic demyelinating and gliotic changes rather than acute vasogenic edema, consistent 
with the slow progression of the lesion. Contrast-enhanced T1 sequences demonstrated 
intense contrast enhancement in the non-calcified regions of the lesion (Fig 1C). In order to 
assess the nature of the mass more precisely, 18F-fluoro-ethyl-tyrosine positron emission 
tomography (18F-FET-PET) was performed, which displayed marked enhancement of 
tyrosine uptake compatible with metabolically active tissue (Fig. 1D).  
 
- What is the interpretation of the MRI and PET findings? 
- How can the diagnosis be established? 
 
Section 3 
Overall, the imaging findings cannot be considered as typical of Sturge-Weber syndrome or 
any other neurocutaneous syndrome. However, the strong tyrosine uptake indicates 
metabolically active tissue and is suspicious for a malignant tumor. Based on these 
considerations, the decision was made to obtain a biopsy for histopathological assessment. 
A microsurgical open biopsy was undertaken with neuronavigation guidance in a superficial 
isolated lesion including meningeal and cortical samples within high FET uptake and 
contrast-enhancement (Fig. 1E). On gross examination, the tissue was noted to have a gritty 
texture and contained white flecks. Histological analysis revealed an unstructured, 
hypocellular mass with an amorphous vaguely chondroid to finely fibrillar core, somewhat 
resembling fibrocartilage, surrounded by mature lamellar bone and a superficial rind of 
spindle to epithelioid cells (Fig. 1F, upper panels). Coarse cords of lumpy, slightly fibrillar 
matrix appeared to radiate towards the cortical layer of epithelial-like cells. These plump 
cortical cells with nuclear pseudoinclusions (Fig. 1F, lower left) were variably positive for 
epithelial membrane antigen (EMA) compatible with meningothelial origin (Fig. 1F, lower 
right). The MIB1 proliferation was low (<1%) and mostly restricted to the surface cells. Based 
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on the above features and the absence of other elements suggesting a neoplastic process, 
the diagnosis of “calcifying pseudoneoplasm of the neuraxis” was rendered. 
 
Discussion 
 
Calcifying pseudoneoplasms of the neuraxis (CAPNON) are rare lesions of the central 
nervous system (CNS) with only few patients reported to date [1-10]. CAPNON can occur 
both intracranially and spinally without a predominant localization. It has been described in 
patients aging from 6 to 68 years with a preponderance of males [3]. The clinical symptoms 
and signs vary and depend on the localization of the mass with seizures as the most frequent 
symptom if the lesion is located intracranially [1, 2]. Of note, CAPNON is a descriptive 
diagnosis and the underlying pathological process is largely unknown. By definition, 
CAPNON is a discrete hypocellular, chondrocalcific, occasionally ossified mass that is 
covered by a surface layer of epithelioid cells of presumed meningothelial origin. According 
to the current interpretation, a reactive rather than a hamartomatous lesion has been 
assumed [2]. Other authors have suggested that the lesion represents abortive bone 
formation [7] or an extremely rare variant of a very low grade neoplasm [8]. CAPNONs 
present with distinctive imaging features as is illustrated in our case. CT scans typically show 
a densely calcified lesion [1], whereas MRI mostly reveals hypointense T1 and T2 signals 
with mild and inhomogeneous internal or rim contrast enhancement [1, 4].  
The present case adds some novel aspects and is of particular interest because of the 
radiological documentation covering a period of 17 years which demonstrates that these 
lesions can grow over a very long period of time. Furthermore, this is the first report on the 
use of FET-PET in a CAPNON patient. The MRI demonstrated marked contrast 
enhancement in the non-calcified peripheral regions of the mass and a distinct T2/FLAIR 
signal alteration (Fig. 1C), which differs from other reports. Furthermore, our patient 
underwent an 18F-FET-PET scan, which displayed profoundly increased tyrosine uptake (Fig. 
1D); however, FET-PET has not been previously reported in CAPNON patients. Of interest, 
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the results of the PET suggest the presence of tissue with high activity. Together with the CT 
and MRI findings this led to the initial assumption of a malignant tumor. However, the 
histopathological features shown in our case did not support the diagnosis of a malignant 
tumor, but displayed the characteristic features of CAPNON. The histopathological 
differential diagnosis encompasses tumoral calcinosis as seen in neoplasms such as 
osteosarcoma, chondrosarcoma, meningioma or even gliomas; however, histological 
evidence of a neoplastic process was lacking.  Alternatively, since the lesion could not be 
completely excised, another entity not sampled by the surgical procedure cannot be 
excluded.  
Our patient had a longstanding history of seizures that spanned over 20 years. The 
radiological documentation covers 17 years and indicates a clear progression of the lesion 
within this period. Resection has been proposed as the most appropriate treatment for 
CAPNON [3]. However, large lesions as in our case may not be amenable to complete 
resection. Owing to the lack of larger series, the value of complete vs. partial resection 
remains speculative. However, given the continuous growth of the mass in our patient, 
complete resection – if considered feasible without causing neurological deficits – may be the 
preferred approach. Partial resection may help to reduce the mass effect and neurological 
symptoms but may not prevent further growth. Because of the lack of any other therapeutic 
approach than surgery, complete resection may be the only option to prevent continuous 
growth of CAPNON as in our case. Another important aspect of surgery is the collection of 
tissue which allows for histopathological confirmation of CAPNON and the exclusion of other 
differential diagnoses. 
The progressive growth pattern of the lesion in our patient and the high activity assessed by 
FET-PET challenge the view that CAPNON represents an entirely benign lesion, despite the 
lack of histological signs of malignancy. Other treatment modalities in patients with non-
resectable CAPNON have not been established so far and the potential benefit of medical 
treatment such as steroid administration or more aggressive approaches such as 
chemotherapy or irradiation needs further investigation.  
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Figure legend 
 
Imaging findings, intraoperative view and histological analyses 
CT scans of the head were obtained at the age of 13 (A) and 30 (B). C. MRI findings on the 
axial T1- and T2/FLAIR-weighted sequences as well as axial contrast-enhanced T1-
sequences. D. FET-PET: red- and yellow-marked regions correspond to areas with high 
activity. E. The intraoperative view during open biopsy of the mass. F. At low magnification, 
the distinctive hypocellular appearance of CAPNON is characterized by a core of amorphous 
basophilic material (*), loose bands of spindle cells (**), and in this example, ossified tissue 
(***), considered a feature of more chronic lesions (upper left, HE, 50x). The vaguely 
chondroid to finely fibrillar core (+), somewhat resembling fibrocartilage, abuts a superficial 
rind of spindle to epithelioid cells (++ upper right, HE, 100x). Coarse cords of lumpy, slightly 
fibrillar matrix (×) appear to radiate towards a cortical layer of epithelial-like cells with 
occasional nuclear pseudoinclusions (×× lower left, HE, 200x). The epithelioid cells (‡), 
presumably of meningothelial origin, label epithelial membrane antigen (lower right, EMA, 
200x). 
 
  
Tonder 8 
 
References 
 
 
1. Aiken AH, Akgun H, Tihan T, Barbaro N, Glastonbury C. Calcifying pseudoneoplasms 
of the neuraxis: CT, MR imaging, and histologic features. AJNR Am J Neuroradiol 
2009;30:1256-1260 
2. Bertoni F, Unni KK, Dahlin DC, Beabout JW, Onofrio BM. Calcifying 
pseudoneoplasms of the neural axis. J Neurosurg 1990;72:42-48 
3. Stienen MN, Abdulazim A, Gautschi OP, Schneiderhan TM, Hildebrandt G, Lücke S. 
Calcifying pseudoneoplasms of the neuraxis (CAPNON): clinical features and 
therapeutic options. Acta Neurochir 2013;55:9-17 
4. Hodges TR, Karikari IO, Nimjee SM, et al. Calcifying pseudoneoplasm of the 
cerebellopontine angle: case report. Neurosurgery 2011;69:onsE117–onsE120 
5. Liccardo G, Lunardi P, Menniti A, Floris R, Pastore FS, Fraioli B. Calcifying pseudo-
tumor of the spine: description of a case and review of the literature. Eur Spine J 
2003;12:548-551 
6. Mayr MT, Hunter S, Erwood SC, Haid RW Jr. Calcifying pseudoneoplasms of the 
spine with myelopathy. Report of two cases. J Neurosurg 2000;93:291-293 
7. Garen PD, Powers JM, King JS, Perot PL Jr. Intracranial fibro-osseous lesion. Case 
report. J Neurosurg 1989;70:475–477 
8. Smith DM, Berry AD 3rd. Unusual fibro-osseous lesion of the spinal cord with positive 
staining for glial fibrillary acidic protein and radiological progression: a case report. 
Hum Pathol 1994;25:835–838 
9. Tatke M, Singh AK, Gupta V. Calcifying pseudoneoplasm of the CNS. Br J Neurosurg 
2001;15:521-523 
10. Tong D, Karunaratne N, Howe G, Spencer D, Manolios N. Clinical images: calcifying 
pseudoneoplasm of the neuraxis. Arthritis Rheum 2010;62:704 
 
 
 
 
 
A B 
C D 
F 
Fig. 1 
E 
× 
‡ 
++ 
+ 
*** 
* 
** 
×× 
